Eli Lilly Stock Drops as CVS Excludes Zepbound.
Reading
Eli Lilly's stock had some problems on Thursday. This was after news about its weight-loss drug, Zepbound. CVS Health shared some details about what drugs they will cover.
CVS Health said Novo Nordisk drugs will be preferred. These drugs are Wegovy and Saxenda. Zepbound will not be on the list of covered drugs after July 1.
This decision could make it harder to get Zepbound. Many people cannot pay for this medicine themselves. The list of covered drugs is very important for people's health.
CVS Health helps many people get their prescription drugs. They decide which medicines will be covered. Employers and insurers use this list to decide what to pay for.
CVS Health will sell Wegovy at a lower price. It will cost about $500 each month for some people. Zepbound is very popular, with sales increasing to $2.3 billion.
Questions
What happened to Eli Lilly's stock on Thursday?
Eli Lilly's stock had some problems after news about its weight-loss drug, Zepbound.
Which drugs will CVS Health prefer?
CVS Health will prefer Novo Nordisk drugs, which are Wegovy and Saxenda.
How much will Wegovy cost for some people?
Wegovy will cost about $500 each month for some people.
Discuss
Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.
Read a new article every day anddiscuss it with AI at lingolette.com